Private Equity investments in pharma touch $400 m
Private Equity investments in pharma touch $400 m

Private Equity (PE) investments in the domestic healthcare and pharma industry have touched around $400 million during the first nine months of the year. This trend is set to accelerate as companies go for overseas acquisitions, hive off their R&D units, and Foreign Currency Convertible Bonds (FCCB) lose their sheen.

whatsapp--v1